1,600 results on '"Laboratory Infection"'
Search Results
2. Viral Specific T Cell Therapy for COVID-19 Related Pneumonia
- Published
- 2024
3. Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
- Author
-
National Cancer Institute (NCI)
- Published
- 2024
4. Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma
- Author
-
National Cancer Institute (NCI) and California Institute for Regenerative Medicine (CIRM)
- Published
- 2024
5. Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy
- Author
-
National Cancer Institute (NCI)
- Published
- 2024
6. Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects
- Author
-
PPD DEVELOPMENT, LP
- Published
- 2024
7. Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization
- Author
-
Janssen Scientific Affairs, LLC and Jennifer Woyach, Principal Investigator
- Published
- 2023
8. Trachymyrmex septentrionalis ants promote fungus garden hygiene using Trichoderma-derived metabolite cues.
- Author
-
Kyle, Kathleen, Puckett, Sara, Caraballo-Rodríguez, Andrés, Rivera-Chávez, José, Samples, Robert, Earp, Cody, Raja, Huzefa, Pearce, Cedric, Ernst, Madeleine, van der Hooft, Justin, Adams, Madison, Oberlies, Nicholas, Dorrestein, Pieter, Klassen, Jonathan, and Balunas, Marcy
- Subjects
Trichoderma ,comparative metabolomics ,fungus-growing ants ,host–microbe interactions ,peptaibols ,Animals ,Trichoderma ,Ants ,Gardens ,Cues ,Laboratory Infection ,Symbiosis ,Peptaibols - Abstract
Fungus-growing ants depend on a fungal mutualist that can fall prey to fungal pathogens. This mutualist is cultivated by these ants in structures called fungus gardens. Ants exhibit weeding behaviors that keep their fungus gardens healthy by physically removing compromised pieces. However, how ants detect diseases of their fungus gardens is unknown. Here, we applied the logic of Kochs postulates using environmental fungal community gene sequencing, fungal isolation, and laboratory infection experiments to establish that Trichoderma spp. can act as previously unrecognized pathogens of Trachymyrmex septentrionalis fungus gardens. Our environmental data showed that Trichoderma are the most abundant noncultivar fungi in wild T. septentrionalis fungus gardens. We further determined that metabolites produced by Trichoderma induce an ant weeding response that mirrors their response to live Trichoderma. Combining ant behavioral experiments with bioactivity-guided fractionation and statistical prioritization of metabolites in Trichoderma extracts demonstrated that T. septentrionalis ants weed in response to peptaibols, a specific class of secondary metabolites known to be produced by Trichoderma fungi. Similar assays conducted using purified peptaibols, including the two previously undescribed peptaibols trichokindins VIII and IX, suggested that weeding is likely induced by peptaibols as a class rather than by a single peptaibol metabolite. In addition to their presence in laboratory experiments, we detected peptaibols in wild fungus gardens. Our combination of environmental data and laboratory infection experiments strongly support that peptaibols act as chemical cues of Trichoderma pathogenesis in T. septentrionalis fungus gardens.
- Published
- 2023
9. Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 (RESCUE1-19)
- Author
-
National Cancer Institute (NCI) and Mohammad K. Khan, Principal Investigator
- Published
- 2023
10. Comportamentos na desinfeção das impressões dentárias por médicos dentistas e técnicos de prótese de Viseu
- Author
-
Marinheiro Marques, Marta Cristina, Rebelo Amorim, Susana Carina, Soares Framegas de Araújo, Filipe Miguel, Figueiral, Maria Helena, and Maia Correia, André Ricardo
- Published
- 2014
- Full Text
- View/download PDF
11. Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients
- Author
-
National Cancer Institute (NCI)
- Published
- 2023
12. Immuno-epidemiology of chronic bacterial and helminth co-infections: Observations from the field and evidence from the laboratory
- Author
-
Pathak, Ashutosh K., Pelensky, Chad, Boag, Brian, and Cattadori, Isabella M.
- Published
- 2012
- Full Text
- View/download PDF
13. A large exposure to Brucella melitensis in a diagnostic laboratory
- Author
-
Sam, I.-C., Karunakaran, R., Kamarulzaman, A., Ponnampalavanar, S., Syed Omar, S.F., Ng, K.P., Mohd Yusof, M.Y., Hooi, P.S., Jafar, F.L., and AbuBakar, S.
- Published
- 2012
- Full Text
- View/download PDF
14. Dasatinib for the Treatment of Moderate and Severe COVID-19
- Author
-
National Cancer Institute (NCI)
- Published
- 2022
15. Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)
- Author
-
National Cancer Institute (NCI)
- Published
- 2022
16. Risques infectieux et prévention des accidents exposant au sang et aux liquides biologiques
- Author
-
Abiteboul, Dominique, Pellissier, Gérard, Tosini, William, and Bouvet, Elisabeth
- Published
- 2010
- Full Text
- View/download PDF
17. Complications After Lower Third Molar Surgery
- Author
-
Branislav Bajkin, MD, DMD, PhD, University Full Professor, Vice Dean for PhD studies
- Published
- 2022
18. Tocilizumab for Patients With Cancer and COVID-19 Disease
- Published
- 2021
19. Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19
- Author
-
National Cancer Institute (NCI)
- Published
- 2021
20. Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year
- Author
-
Oregon Health and Science University and Jennifer Saultz, Principal Investigator
- Published
- 2021
21. Francisella tularensis Transmission by Solid Organ Transplantation, 20171.
- Author
-
Nelson, Christina A, Murua, Christian, Jones, Jefferson M, Mohler, Kelli, Zhang, Ying, Wiggins, Landon, Kwit, Natalie A, Respicio-Kingry, Laurel, Kingry, Luke C, Petersen, Jeannine M, Brown, Jennifer, Aslam, Saima, Krafft, Melissa, Asad, Shadaba, Dagher, Hikmat N, Ham, John, Medina-Garcia, Luis H, Burns, Kevin, Kelley, Walter E, Hinckley, Alison F, Annambhotla, Pallavi, Carifo, Karen, Gonzalez, Anthony, Helsel, Elizabeth, Iser, Joseph, Johnson, Michael, Fritz, Curtis L, Basavaraju, Sridhar V, and Tularemia in Transplant Recipients Investigation Team
- Subjects
Tularemia in Transplant Recipients Investigation Team ,Humans ,Francisella tularensis ,Tularemia ,Kidney Transplantation ,Heart Transplantation ,Organ Transplantation ,Sentinel Surveillance ,Health Care Surveys ,History ,21st Century ,Middle Aged ,Tissue Donors ,Blood Donors ,Female ,Male ,United States ,bacteria ,biological warfare ,bioterrorism and preparedness ,laboratory infection ,prevention and control ,tissue donors ,transplant ,transplantation ,History ,21st Century ,Microbiology ,Clinical Sciences ,Medical Microbiology ,Public Health and Health Services - Abstract
In July 2017, fever and sepsis developed in 3 recipients of solid organs (1 heart and 2 kidneys) from a common donor in the United States; 1 of the kidney recipients died. Tularemia was suspected only after blood cultures from the surviving kidney recipient grew Francisella species. The organ donor, a middle-aged man from the southwestern United States, had been hospitalized for acute alcohol withdrawal syndrome, pneumonia, and multiorgan failure. F. tularensis subsp. tularensis (clade A2) was cultured from archived spleen tissue from the donor and blood from both kidney recipients. Whole-genome multilocus sequence typing indicated that the isolated strains were indistinguishable. The heart recipient remained seronegative with negative blood cultures but had been receiving antimicrobial drugs for a medical device infection before transplant. Two lagomorph carcasses collected near the donor's residence were positive by PCR for F. tularensis subsp. tularensis (clade A2). This investigation documents F. tularensis transmission by solid organ transplantation.
- Published
- 2019
22. Ahead of Print - Francisella tularensis Transmission by Solid Organ Transplantation, 2017 - Volume 25, Number 4—April 2019 - Emerging Infectious Diseases journal - CDC
- Author
-
Nelson, Christina A, Murua, Christian, Jones, Jefferson M, Mohler, Kelli, Zhang, Ying, Wiggins, Landon, Kwit, Natalie A, Respicio-Kingry, Laurel, Kingry, Luke C, Petersen, Jeannine M, Brown, Jennifer, Aslam, Saima, Krafft, Melissa, Asad, Shadaba, Dagher, Hikmat N, Ham, John, Medina-Garcia, Luis H, Burns, Kevin, Kelley, Walter E, Hinckley, Alison F, Annambhotla, Pallavi, Carifo, Karen, Gonzalez, Anthony, Helsel, Elizabeth, Iser, Joseph, Johnson, Michael, Fritz, Curtis L, and Basavaraju, Sridhar V
- Subjects
Biotechnology ,Infectious Diseases ,Organ Transplantation ,Prevention ,Transplantation ,Kidney Disease ,Renal and urogenital ,Infection ,Good Health and Well Being ,Blood Donors ,Female ,Francisella tularensis ,Health Care Surveys ,Heart Transplantation ,History ,21st Century ,Humans ,Kidney Transplantation ,Male ,Middle Aged ,Sentinel Surveillance ,Tissue Donors ,Tularemia ,Tularemia in Transplant Recipients Investigation Team ,United States ,bacteria ,biological warfare ,bioterrorism and preparedness ,laboratory infection ,prevention and control ,tissue donors ,transplant ,transplantation ,Clinical Sciences ,Medical Microbiology ,Public Health and Health Services ,Microbiology - Abstract
In July 2017, fever and sepsis developed in 3 recipients of solid organs (1 heart and 2 kidneys) from a common donor in the United States; 1 of the kidney recipients died. Tularemia was suspected only after blood cultures from the surviving kidney recipient grew Francisella species. The organ donor, a middle-aged man from the southwestern United States, had been hospitalized for acute alcohol withdrawal syndrome, pneumonia, and multiorgan failure. F. tularensis subsp. tularensis (clade A2) was cultured from archived spleen tissue from the donor and blood from both kidney recipients. Whole-genome multilocus sequence typing indicated that the isolated strains were indistinguishable. The heart recipient remained seronegative with negative blood cultures but had been receiving antimicrobial drugs for a medical device infection before transplant. Two lagomorph carcasses collected near the donor's residence were positive by PCR for F. tularensis subsp. tularensis (clade A2). This investigation documents F. tularensis transmission by solid organ transplantation.
- Published
- 2019
23. Assessment of knowledge, attitude, and practice regarding safety laboratory measures during COVID-19 pandemic – A cross-sectional study among oral pathologists in Kerala
- Author
-
Plakkil Viswanathan Deepthi, P M Shameena, Sujatha Varma, and M N Navajeevraj
- Subjects
knowledge ,laboratory infection ,sars-cov-2 ,surveys and questionnaires ,Dentistry ,RK1-715 - Published
- 2022
- Full Text
- View/download PDF
24. Clinical and Laboratory Factors for the Progression of Severe Dengue Among Hospitalized Patients During an Upsurge.
- Subjects
MEDICAL personnel ,HEMORRHAGIC fever ,RNA virus infections ,LABORATORY infections ,LEUKOCYTE count ,DENGUE hemorrhagic fever - Abstract
The article discusses a clinical trial, NCT06697041, focusing on identifying factors for the progression of severe Dengue in hospitalized patients. The trial aims to study various clinical and laboratory factors, including host factors, comorbidities, and immune parameters. The study is being conducted in Bangladesh, a country where dengue fever is hyperendemic, with a higher case fatality rate this year. The research aims to improve understanding of severe dengue and its link with dengue fever in the country, with a focus on identifying the burden of severe dengue and developing better treatment approaches. [Extracted from the article]
- Published
- 2024
25. Genome Sequence Analysis and Characterization of Shiga Toxin 2 Production by Escherichia coli O157:H7 Strains Associated With a Laboratory Infection.
- Author
-
Eppinger, Mark, Almería, Sonia, Allué-Guardia, Anna, Bagi, Lori K., Kalalah, Anwar A., Gurtler, Joshua B., and Fratamico, Pina M.
- Subjects
ESCHERICHIA coli O157:H7 ,NUCLEOTIDE sequencing ,SEQUENCE analysis ,HEMOLYTIC-uremic syndrome ,ESCHERICHIA coli - Abstract
A laboratory-acquired E. coli O157:H7 infection with associated severe sequelae including hemolytic uremic syndrome occurred in an individual working in the laboratory with a mixture of nalidixic acid-resistant (Nal
R ) O157:H7 mutant strains in a soil-biochar blend. The patient was hospitalized and treated with an intravenous combination of metronidazole and levofloxacin. The present study investigated the source of this severe laboratory acquired infection and further examined the influence of the antibiotics used during treatment on the expression and production of Shiga toxin. Genomes of two Stx2a -and eae -positive O157:H7 strains isolated from the patient's stool were sequenced along with two pairs of the wt strains and their derived NalR mutants used in the laboratory experiments. High-resolution SNP typing determined the strains' individual genetic relatedness and unambiguously identified the two laboratory-derived NalR mutant strains as the source of the researcher's life-threatening disease, rather than a conceivable ingestion of unrelated O157:H7 isolates circulating at the same time. It was further confirmed that in sublethal doses, the antibiotics increased toxin expression and production. Our results support a simultaneous co-infection with clinical strains in the laboratory, which were the causative agents of previous O157:H7 outbreaks, and further that the administration of antibiotics may have impacted the outcome of the infection. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
26. Genome Sequence Analysis and Characterization of Shiga Toxin 2 Production by Escherichia coli O157:H7 Strains Associated With a Laboratory Infection
- Author
-
Mark Eppinger, Sonia Almería, Anna Allué-Guardia, Lori K. Bagi, Anwar A. Kalalah, Joshua B. Gurtler, and Pina M. Fratamico
- Subjects
Shiga toxin (Stx) producing Escherichia coli (STEC) ,O157:H7 ,laboratory infection ,genome sequencing ,single nucleotide polymorphisms (SNP) typing ,Microbiology ,QR1-502 - Abstract
A laboratory-acquired E. coli O157:H7 infection with associated severe sequelae including hemolytic uremic syndrome occurred in an individual working in the laboratory with a mixture of nalidixic acid-resistant (NalR) O157:H7 mutant strains in a soil-biochar blend. The patient was hospitalized and treated with an intravenous combination of metronidazole and levofloxacin. The present study investigated the source of this severe laboratory acquired infection and further examined the influence of the antibiotics used during treatment on the expression and production of Shiga toxin. Genomes of two Stx2a-and eae-positive O157:H7 strains isolated from the patient’s stool were sequenced along with two pairs of the wt strains and their derived NalR mutants used in the laboratory experiments. High-resolution SNP typing determined the strains’ individual genetic relatedness and unambiguously identified the two laboratory-derived NalR mutant strains as the source of the researcher’s life-threatening disease, rather than a conceivable ingestion of unrelated O157:H7 isolates circulating at the same time. It was further confirmed that in sublethal doses, the antibiotics increased toxin expression and production. Our results support a simultaneous co-infection with clinical strains in the laboratory, which were the causative agents of previous O157:H7 outbreaks, and further that the administration of antibiotics may have impacted the outcome of the infection.
- Published
- 2022
- Full Text
- View/download PDF
27. Molecular investigation of infection sources and transmission chains of brucellosis in Zhejiang, China
- Author
-
Heng Wang, Wei-min Xu, Kuang-ji Zhu, Su-juan Zhu, Hong-fang Zhang, Jia Wang, Yang Yang, Feng-yao Shao, Neng-ming Jiang, Zhen-yang Tao, Hang-yi Jin, Yi Tang, Liang-liang Huo, Fang Dong, Zhen-jun Li, Hua Ding, and Zhi-guo Liu
- Subjects
B. melitensis ,B. abortus ,MLVA ,trace-back ,laboratory infection ,Zhejiang province ,Infectious and parasitic diseases ,RC109-216 ,Microbiology ,QR1-502 - Abstract
ABSTRACTIn the present study, a total of 7793 samples from 5 different types of hosts were collected and tested, with a seroprevalence of 2.4% (184/7793). Although the seroprevalence of human and animal brucellosis is relatively low, numbers of human brucellosis cases reported have increased continuously from 2004 to 2018. A total of 118 Brucella strains containing 4 biotypes were obtained, including Brucella melitensis bv.1 (n = 8) and bv.3 (n = 106), Brucella abortus bv.3 (n = 3) and bv.7 (n = 1). Twenty-one shared MLVA-16 genotypes, each composed of 2 to 19 strains obtained from different hosts, suggest the occurrence of a brucellosis outbreak epidemic with multiple source points and laboratory infection events. Moreover, 30 shared MLVA-16 genotypes were observed among 59.6% (68/114) B. melitensis isolates from Zhejiang and strains from other 21 different provinces, especially northern provinces, China. The analysis highlighted the imported nature of the strains from all over the northern provinces with a dominant part from the developed areas of animal husbandry. These data revealed a potential transmission pattern of brucellosis in this region, due to introduced infected sheep leading to a brucellosis outbreak epidemic, and eventually causing multiple laboratory infection events. It is urgent to strengthen the inspection and quarantine of the introduced animals.
- Published
- 2020
- Full Text
- View/download PDF
28. Brucella related myocarditis
- Author
-
Wendt, Sebastian, Lippmann, Norman, Fahnert, Jeanette, Rodloff, Arne C., and Lübbert, Christoph
- Published
- 2018
- Full Text
- View/download PDF
29. Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2.
- Author
-
Wang, Kaijin, Zhu, Xuetong, and Xu, Jiancheng
- Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen that causes coronavirus disease 2019 (COVID-19), which was first detected in Wuhan, China. Recent studies have updated the epidemiologic and clinical characteristics of COVID-19 continuously. In China, diagnostic tests and laboratory tests of specimens from persons under investigation are usually performed in a biosafety level 2 environment. Laboratory staff may be at greater risk of exposure due to a higher concentration and invasiveness of emerging pathogens. Current infection prevention strategies are based on lessons learned from severe acute respiratory syndrome, expert judgments, and related regulations. This article summarizes biosafety prevention and control measures performed in severe acute respiratory syndrome coronavirus 2 testing activities and provides practical suggestions for laboratory staff to avoid laboratory-acquired infections in dealing with public health emergencies. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
30. Georg von Hofmann-Wellenhof, vor 130 Jahren erstes Opfer am Beginn der Erforschung der Infektionskrankheiten in Österreich.
- Author
-
Flamm, Heinz
- Abstract
Copyright of Wiener Medizinische Wochenschrift is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2020
- Full Text
- View/download PDF
31. Laboratory-acquired infections and pathogen escapes worldwide between 2000 and 2021: a scoping review.
- Author
-
Blacksell SD, Dhawan S, Kusumoto M, Le KK, Summermatter K, O'Keefe J, Kozlovac JP, Almuhairi SS, Sendow I, Scheel CM, Ahumibe A, Masuku ZM, Bennett AM, Kojima K, Harper DR, and Hamilton K
- Subjects
- Animals, Cattle, Humans, Salmonella enteritidis, Salmonella typhimurium, Influenza A Virus, H5N1 Subtype, Laboratory Infection, Yersinia pestis
- Abstract
Laboratory-acquired infections (LAIs) and accidental pathogen escape from laboratory settings (APELS) are major concerns for the community. A risk-based approach for pathogen research management within a standard biosafety management framework is recommended but is challenging due to reasons such as inconsistency in risk tolerance and perception. Here, we performed a scoping review using publicly available, peer-reviewed journal and media reports of LAIs and instances of APELS between 2000 and 2021. We identified LAIs in 309 individuals in 94 reports for 51 pathogens. Eight fatalities (2·6% of all LAIs) were caused by infection with Neisseria meningitidis (n=3, 37·5%), Yersinia pestis (n=2, 25%), Salmonella enterica serotype Typhimurium (S Typhimurium; n=1, 12·5%), or Ebola virus (n=1, 12·5%) or were due to bovine spongiform encephalopathy (n=1, 12·5%). The top five LAI pathogens were S Typhimurium (n=154, 49·8%), Salmonella enteritidis (n=21, 6·8%), vaccinia virus (n=13, 4·2%), Brucella spp (n=12, 3·9%), and Brucella melitensis (n=11, 3·6%). 16 APELS were reported, including those for Bacillus anthracis, SARS-CoV, and poliovirus (n=3 each, 18·8%); Brucella spp and foot and mouth disease virus (n=2 each, 12·5%); and variola virus, Burkholderia pseudomallei, and influenza virus H5N1 (n=1 each, 6·3%). Continual improvement in LAI and APELS management via their root cause analysis and thorough investigation of such incidents is essential to prevent future occurrences. The results are biased due to the reliance on publicly available information, which emphasises the need for formalised global LAIs and APELS reporting to better understand the frequency of and circumstances surrounding these incidents., Competing Interests: Declaration of interests We declare no competing interests., (Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
32. Morphological comparison of genetically differentiated Polymorphus cf. minutus types.
- Author
-
Grabner, Daniel, Doliwa, Annemie, Bulantová, Jana, Horák, Petr, and Sures, Bernd
- Subjects
- *
GAMMARUS pulex , *FISHER discriminant analysis , *DUCKS , *OVIPARITY - Abstract
In the present study, we analyzed the morphology of three genetic types of the bird-infecting acanthocephalan Polymorphus cf. minutus (PspT1, PspT2, PspT3), mainly based on the cystacanth-stage obtained from amphipods (Gammarus fossarum, Gammarus pulex, Gammarus roeselii, Echinogammarus spp.). Males and females were pooled as there was no considerable difference between the sexes concerning the hook measurements. Additionally, we conducted a laboratory infection of one domestic duck for each Polymorphus type, to compare their performance and localization in this host species, and to obtain adult specimens for morphological comparison. The recovery rate from the ducks 4 weeks after infection was 16% for PspT1, 23.8% for PspT2, and 25% for PspT3. The adult worms were gravid, and the females contained mature eggs. Hook size did not differ considerably between cystacanths and adults of the respective type. The three Polymorphus types could be distinguished based on the cystacanth stage by a linear discriminant analysis that included hook measurements, proboscis length, proboscis width, and number of longitudinal hook rows and hooks per row. Furthermore, PspT3 was more different from PspT1 and PspT2 than the latter types from each other. Mainly the number of longitudinal hook rows differed in PspT3 from the existing descriptions of P. minutus (mainly 14 vs. mainly 16 rows). Potentially, PspT3 could be a non-indigenous parasite that was introduced with G. roeselii and that adapted to use the indigenous G. pulex as a host, while PspT2 might have been introduced to central Europe together with Echinogammarus spp. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
33. Francisella tularensis Transmission by Solid Organ Transplantation, 20171.
- Author
-
Nelson, Christina A., Murua, Christian, Jones, Jefferson M., Mohler, Kelli, Ying Zhang, Wiggins, Landon, Kwit, Natalie A., Respicio-Kingry, Laurel, Kingry, Luke C., Petersen, Jeannine M., Brown, Jennifer, Aslam, Saima, Krafft, Melissa, Asad, Shadaba, Dagher, Hikmat N., Ham, John, Medina-Garcia, Luis H., Burns, Kevin, Kelley, Walter E., and Hinckley, Alison F.
- Subjects
- *
TRANSPLANTATION of organs, tissues, etc. , *FRANCISELLA tularensis , *GRAM-negative bacteria , *HEART transplantation , *HISTORY , *KIDNEY transplantation , *SENTINEL health events , *SURVEYS , *TULAREMIA , *INFECTIOUS disease transmission - Abstract
In July 2017, fever and sepsis developed in 3 recipients of solid organs (1 heart and 2 kidneys) from a common donor in the United States; 1 of the kidney recipients died. Tularemia was suspected only after blood cultures from the surviving kidney recipient grew Francisella species. The organ donor, a middle-aged man from the southwestern United States, had been hospitalized for acute alcohol withdrawal syndrome, pneumonia, and multiorgan failure. F. tularensis subsp. tularensis (clade A2) was cultured from archived spleen tissue from the donor and blood from both kidney recipients. Whole-genome multilocus sequence typing indicated that the isolated strains were indistinguishable. The heart recipient remained seronegative with negative blood cultures but had been receiving antimicrobial drugs for a medical device infection before transplant. Two lagomorph carcasses collected near the donor's residence were positive by PCR for F. tularensis subsp. tularensis (clade A2). This investigation documents F. tularensis transmission by solid organ transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
34. Francisella tularensis Transmission by Solid Organ Transplantation, 20171.
- Author
-
Nelson, Christina A., Murua, Christian, Jones, Jefferson M., Mohler, Kelli, Ying Zhang, Wiggins, Landon, Kwit, Natalie A., Respicio-Kingry, Laurel, Kingry, Luke C., Petersen, Jeannine M., Brown, Jennifer, Aslam, Saima, Krafft, Melissa, Asad, Shadaba, Dagher, Hikmat N., Ham, John, Medina-Garcia, Luis H., Burns, Kevin, Kelley, Walter E., and Hinckley, Alison F.
- Subjects
TRANSPLANTATION of organs, tissues, etc. ,FRANCISELLA tularensis ,GRAM-negative bacteria ,HEART transplantation ,HISTORY ,KIDNEY transplantation ,SENTINEL health events ,SURVEYS ,TULAREMIA ,INFECTIOUS disease transmission - Abstract
In July 2017, fever and sepsis developed in 3 recipients of solid organs (1 heart and 2 kidneys) from a common donor in the United States; 1 of the kidney recipients died. Tularemia was suspected only after blood cultures from the surviving kidney recipient grew Francisella species. The organ donor, a middle-aged man from the southwestern United States, had been hospitalized for acute alcohol withdrawal syndrome, pneumonia, and multiorgan failure. F. tularensis subsp. tularensis (clade A2) was cultured from archived spleen tissue from the donor and blood from both kidney recipients. Whole-genome multilocus sequence typing indicated that the isolated strains were indistinguishable. The heart recipient remained seronegative with negative blood cultures but had been receiving antimicrobial drugs for a medical device infection before transplant. Two lagomorph carcasses collected near the donor's residence were positive by PCR for F. tularensis subsp. tularensis (clade A2). This investigation documents F. tularensis transmission by solid organ transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
35. Two Cases of Laboratory-acquired Brucellosis
- Author
-
Merve Sefa SAYAR, Dilek Bulut, and Aslı HAYKIR SOLAY
- Subjects
Brucella ,laboratory infection ,biosafety cabinet ,education ,prevention ,Medicine ,Infectious and parasitic diseases ,RC109-216 - Published
- 2018
- Full Text
- View/download PDF
36. Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai.
- Author
-
Wu Q, Wang H, Cai J, Ai J, Li Y, Zhang H, Wang S, Sun F, Wu Y, Zhou J, Wang Y, Yu H, and Zhang W
- Subjects
- Aged, Humans, Aged, 80 and over, COVID-19 Vaccines, Cohort Studies, SARS-CoV-2, China epidemiology, Vaccination, Asymptomatic Infections, Disease Outbreaks prevention & control, COVID-19 epidemiology, COVID-19 prevention & control, Laboratory Infection
- Abstract
Omicron and its sublineages are currently predominant and have triggered epidemiological waves of SARS-CoV-2 around the world due to their high transmissibility and strong immune escape ability. Vaccines are key measures to control the COVID-19 burden. Omicron BA.2 caused a large-scale outbreak in Shanghai since March 2022 and resulted in over 0.6 million laboratory-confirmed infections. The vaccine coverage of primary immunization among residents aged 3 years and older in Shanghai exceeded 90%, and inactivated COVID-19 vaccines were mainly delivered. In the context of high vaccine coverage, we conducted a cohort study to assess vaccine effects on reducing the probability of developing symptoms or severity of disease in infections or nonsevere cases. A total of 48,243 eligible participants were included in this study, the majority of whom had asymptomatic infections (31.0%) and mild-to-moderate illness (67.9%). Domestically developed COVID-19 vaccines provide limited protection to prevent asymptomatic infection from developing into mild-to-moderate illness and durable protection to prevent nonsevere illness from progressing to severe illness caused by Omicron BA.2. Partial vaccination fails to provide effective protection in any situation. The level of vaccine effects on disease progression in the elderly over 80 years old was relatively lower compared with other age groups. Our study results added robust evidence for the vaccine performance against Omicron infection and could improve vaccine confidence.
- Published
- 2023
- Full Text
- View/download PDF
37. Investment in biosafety and biosecurity: the need for a risk-based approach and systematic reporting of laboratory accidents to mitigate laboratory-acquired infections and pathogen escapes.
- Author
-
Blacksell SD, Summermatter K, Masuku ZM, Kojima K, Ross E, Harper DR, and Hamilton K
- Subjects
- Humans, Biosecurity, Laboratories, Containment of Biohazards, Laboratory Infection
- Abstract
Competing Interests: The authors wish to thank David Elliott, UK International Biosecurity Programme, UK, for his input to this Comment and his contributions to the Biosafety Research Roadmap initiative. The Weapons Threat Reduction Program of Global Affairs Canada provided funding for this study. This research was funded in whole, or in part, by the Wellcome Trust (220211). The donors played no role in the writing of the manuscript or the decision to submit it for publication. We declare no competing interests. The authors alone are responsible for the views expressed in this Comment, and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated.
- Published
- 2023
- Full Text
- View/download PDF
38. Evaluating the Clinical and Immune Responses to Spotted Fever Rickettsioses in the Guinea Pig-Tick-Rickettsia System
- Author
-
John V. Stokes, Michael L. Levin, Claire E. Cross, Anne‐Marie L. Ross, Alyssa N. Snellgrove, Bridget V. Willeford, Navatha Alugubelly, and Andrea S. Varela‐Stokes
- Subjects
General Immunology and Microbiology ,General Neuroscience ,Guinea Pigs ,Immunity ,Health Informatics ,Spotted Fever Group Rickettsiosis ,Laboratory Infection ,General Biochemistry, Genetics and Molecular Biology ,Medical Laboratory Technology ,Disease Models, Animal ,Ticks ,Animals ,Humans ,General Pharmacology, Toxicology and Pharmaceutics ,Rickettsia - Abstract
The guinea pig was the original animal model developed for investigating spotted fever rickettsiosis (SFR). This model system has persisted on account of the guinea pig's conduciveness to tick transmission of SFR agents and ability to recapitulate SFR in humans through clinical signs that include fever, unthriftiness, and in some cases the development of an eschar. The guinea pig is the smallest animal model for SFR that allows the collection of multiple blood and skin samples antemortem for longitudinal studies. This unit provides the basic protocols necessary to establish, maintain, and utilize a guinea pig-tick-Rickettsia model for monitoring the course of infection and immune response to an infection by spotted fever group Rickettsia (SFGR) that can be studied at biosafety level 2 (BSL-2) and arthropod containment level 2 (ACL-2); adaptations must be made for BSL-3 agents. The protocols cover methods for tick feeding and colony development, laboratory infection of ticks, tick transmission of Rickettsia to guinea pigs, and monitoring of the course of infection through clinical signs, rickettsial burden, and immune response. It should be feasible to adapt these methods to study other tick-borne pathogens. © 2022 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Tick transmission of SFGR to guinea pigs Support Protocol 1: Laboratory infection of ticks by injection Alternate Protocol 1: Needle inoculation of SFGR to guinea pigs Basic Protocol 2: Monitoring the course of guinea pig rickettsial infection: clinical signs Basic Protocol 3: Monitoring the course of guinea pig rickettsial infection: collection of biological specimens Support Protocol 2: Guinea pig anesthesia Basic Protocol 4: Monitoring rickettsial burden in guinea pigs by multiplex qPCR Basic Protocol 5: Monitoring guinea pig immune response to infection: blood leukocytes by flow cytometry Basic Protocol 6: Monitoring immune response to guinea pig rickettsial infection: leukocyte infiltration of skin at the tick bite site by flow cytometry Basic Protocol 7: Monitoring the immune response to guinea pig rickettsial infection: antibody titer by ELISA Support Protocol 4: Coating ELISA Plates Alternate Protocol 2: Monitoring immune response to guinea pig rickettsial infection: antibody titer by immunofluorescence assay.
- Published
- 2022
39. The Lanzhou Brucella Leak: The Largest Laboratory Accident in the History of Infectious Diseases?
- Author
-
Georgios, Pappas
- Subjects
Microbiology (medical) ,Infectious Diseases ,Accidents ,Humans ,Laboratory Infection ,Brucella ,Communicable Diseases ,Brucellosis - Abstract
An inadequacy in sanitizing processes in a biopharmaceutical plant in Lanzhou, China, during July and August 2019, led to the aerosolization of Brucella that was subsequently spread through wind to nearby settlements and academic institutes, resulting in >10 000 human brucellosis cases, as of November 2020. The leak, possibly the largest laboratory accident in the history of infectious diseases, underlines the particular characteristics of Brucella that have made the pathogen a historical entity in biodefense research and a major cause of laboratory-associated infections. It further underlines the need for enhanced vigilance and strict regulatory interventions in similar facilities.
- Published
- 2022
- Full Text
- View/download PDF
40. Die österreichische Pestkommission in Bombay 1897 und die letzten Pest-Todesfälle in Wien 1898.
- Author
-
Flamm, Heinz
- Abstract
Copyright of Wiener Medizinische Wochenschrift is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2018
- Full Text
- View/download PDF
41. The Experience of the Fight Against COVID-19 in Clinical Laboratory Departments from Chengdu, China
- Author
-
Jian Xu, Pei-Pei Song, Yang Shuzhe, Qin Wang, Qin Zhang, and Liu Chenggui
- Subjects
Risk Management and Healthcare Policy ,2019-20 coronavirus outbreak ,medicine.medical_specialty ,medicine.diagnostic_test ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Health Policy ,Sample processing ,Public Health, Environmental and Occupational Health ,COVID-19 ,Nucleic acid test ,Retrospective cohort study ,Laboratory Infection ,laboratory tests ,Biosafety ,Emergency medicine ,clinical laboratory ,medicine ,business ,Perspectives ,Nucleic acid detection - Abstract
Qin Wang,* Chenggui Liu,* Jian Xu, Peipei Song, Shuzhe Yang, Qin Zhang Department of Clinical Laboratory, Chengdu Womenâs and Childrenâs Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, Peopleâs Republic of China*These authors contributed equally to this workCorrespondence: Qin WangDepartment of Clinical Laboratory, Chengdu Womenâs and Childrenâs Central Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 1617, Riyue Avenue, Qingyang District, Chengdu, 611731, Peopleâs Republic of ChinaTel +86 28 61866000-6267Email 314306221@qq.comObjective: In order to fight against coronavirus disease 2019 (COVID-19) better and to share our experience as a reference for clinical laboratory departments.Methods: This was a retrospective study conducted in the clinical laboratory department of Chengdu Womenâs and Childrenâs Central Hospital in Chengdu, China, from April 2020 to January 2021. The number of nucleic acid and antibody testing specimens of suspected COVID-19 cases was analyzed. The key points of suspected-case sample processing and detection in the clinical laboratory department were summarized. The laboratory was directly involved in the sample processing and testing of suspected cases, the release of reports, and the transfer of specimens to the fever clinic.Results: The number of COVID-19 nucleic acid test specimens in our laboratory ranged from 102 to 2170 per day, and the number of antibody test specimens ranged from 24 to 391 per day. There were four main considerations in the treatment and detection of suspected-case specimens in the clinical laboratory: biosafety management in clinical laboratory departments, measures to ensure the health of the staff, the eight time points for processing suspected-case samples (turn-around time), and key points for the detection of suspected case specimens.Conclusion: The laboratory developed a protective process for COVID-19 antibody and nucleic acid detection during the pandemic. At present, the detection of COVID-19 antibodies and nucleic acids in the clinical laboratory department is orderly, and there have been no cases of laboratory infection.Keywords: COVID-19, clinical laboratory, laboratory tests
- Published
- 2021
- Full Text
- View/download PDF
42. Biosafety of personnel of microbiological laboratories in the context of the Federal Law of the Russian Federation № 492-FZ of December 30, 2020 «On the biological safety of the Russian Federation»
- Author
-
E V, Matosova, B G, Andryukov, M P, Bynina, E I, Drobot, and I N, Lyapun
- Subjects
COVID-19 ,Humans ,Containment of Biohazards ,Laboratories ,Laboratory Infection ,Pandemics - Abstract
One of the most important requirements for the personnel of microbiological laboratories working with pathogenic and infectious agents is the observance of precautionary measures and the implementation of a set of preventive measures, collectively interpreted as biological safety (biosafety). To a large extent, biosafety problems are also relevant for all clinical laboratories working with biosubstrates, with the potential threat of containing pathogens of bloodborne infections in them. On December 30, 2020, the President of the Russian Federation signed Federal Law № 492 «On the Biological Safety of the Russian Federation» (№ 492-FZ), which regulates the basic legal norms and regulation of biosafety issues, as well as a list of measures to prevent the risks of the spread of infections due to accidents, bioterrorist acts and sabotage. The current pandemic of the coronavirus infection COVID-19 has demonstrated, on the one hand, the epidemiological vulnerability of the single world space, and on the other hand, the decisive influence of biological emergencies on the emergence of negative political and economic processes in the world community. In this regard, the issues of ensuring biosafety in the work of microbiological laboratories in the context of protecting personnel and the environment from accidental or unintentional spread of infections are relevant. Working with pathogenic biological agents in microbiological laboratories is constantly associated with the risk of accidents and possible laboratory infection (laboratory-acquired infections) of employees, environmental pollution if the requirements of regulatory documents on biological safety are not met. In accordance with the requirements of № 492-FZ, in order to prevent biological threats, it is necessary to create a system for monitoring biological risks in microbiological laboratories when working with any infected material.
- Published
- 2022
43. Laboratory infection rates and associated mortality of juvenile Chinook Salmon ( Oncorhynchus tshawytscha ) from parasitic copepod ( Salmincola californiensis )
- Author
-
Carl B. Schreck, James T. Peterson, Michael L. Kent, Justin L. Sanders, and Travis Neal
- Subjects
0301 basic medicine ,Chinook wind ,biology ,Host (biology) ,Parasitic Diseases, Animal ,Veterinary (miscellaneous) ,Temperature ,Zoology ,04 agricultural and veterinary sciences ,Laboratory Infection ,Aquatic Science ,biology.organism_classification ,Copepoda ,Fish Diseases ,03 medical and health sciences ,030104 developmental biology ,Salmon ,040102 fisheries ,Animals ,0401 agriculture, forestry, and fisheries ,Oncorhynchus ,Salmincola californiensis ,Juvenile ,Parasite hosting ,Copepod - Abstract
Pacific salmon (Oncorhynchus spp.) rearing in lakes and reservoirs above dams have been known to become heavily infected with an ectoparasitic copepod (Salmincola californiensis). Little is known about the factors that affect the parasite infection prevalence and intensity. However, previous research suggests that the parasite may negatively affect the fitness and survival of the host fish. The effect of water temperature, confinement and the density of the free-swimming infectious stage of S. californiensis, the copepodid, on infection prevalence and intensity was evaluated by experimentally exposing juvenile Chinook Salmon (O. tshawytscha). Infection rates observed in wild populations were achieved under warm water (15-16°C) and high copepodid density (150-300/L) treatment conditions. Infection prevalence and intensity were also significantly higher in larger fish. During the infection experiment, 4.5% of infected fish died within 54 days with mortality significantly related to copepod infection intensity. The potential for autoinfection was compared to cross-infection by cohabitation of infected fish with naïve fish. Previously infected fish had significantly greater infection intensity compared with naïve fish, indicating that infected fish can be reinfected and that they may be more susceptible than naïve fish.
- Published
- 2021
- Full Text
- View/download PDF
44. Brucella related myocarditis
- Author
-
Sebastian Wendt, Norman Lippmann, Jeanette Fahnert, Arne C. Rodloff, and Christoph Lübbert
- Subjects
Brucella myocarditis ,Brucellosis ,Brucella melitensis ,laboratory infection ,zoonosis ,cardiac magnetic resonance imaging ,Infectious and parasitic diseases ,RC109-216 - Published
- 2018
- Full Text
- View/download PDF
45. Laboratory-acquired Buffalopox Virus Infection, India
- Author
-
Thachamvally Riyesh, Shanmugasundaram Karuppusamy, Bidhan C. Bera, Sanjay Barua, Nitin Virmani, Sarita Yadav, Rajesh K. Vaid, Taruna Anand, Manish Bansal, Praveen Malik, Inderjeet Pahuja, and Raj K. Singh
- Subjects
buffalopox virus ,viruses ,vaccinia virus ,biosafety ,laboratory infection ,researcher ,Medicine ,Infectious and parasitic diseases ,RC109-216 - Published
- 2014
- Full Text
- View/download PDF
46. The Effect of Fluctuating Incubation Temperatures on West Nile Virus Infection in Culex Mosquitoes
- Author
-
Bethany L. McGregor, C. Roxanne Connelly, and Joan L. Kenney
- Subjects
Veterinary medicine ,West Nile virus ,Culex ,viruses ,medicine.disease_cause ,Microbiology ,Virus ,law.invention ,law ,Virology ,parasitic diseases ,medicine ,Incubation ,vector competence ,biology ,Culex quinquefasciatus ,fungi ,Culex tarsalis ,Laboratory Infection ,biology.organism_classification ,QR1-502 ,Infectious Diseases ,Transmission (mechanics) ,Vector (epidemiology) ,daily temperature range - Abstract
Temperature plays a significant role in the vector competence, extrinsic incubation period, and intensity of infection of arboviruses within mosquito vectors. Most laboratory infection studies use static incubation temperatures that may not accurately reflect daily temperature ranges (DTR) to which mosquitoes are exposed. This could potentially compromise the application of results to real world scenarios. We evaluated the effect of fluctuating DTR versus static temperature treatments on the infection, dissemination, and transmission rates and viral titers of Culex tarsalis and Culex quinquefasciatus mosquitoes for West Nile virus. Two DTR regimens were tested including an 11 and 15 °C range, both fluctuating around an average temperature of 28 °C. Overall, no significant differences were found between DTR and static treatments for infection, dissemination, or transmission rates for either species. However, significant treatment differences were identified for both Cx. tarsalis and Cx. quinquefasciatus viral titers. These effects were species-specific and most prominent later in the infection. These results indicate that future studies on WNV infections in Culex mosquitoes should consider employing realistic DTRs to reflect interactions most accurately between the virus, vector, and environment.
- Published
- 2021
- Full Text
- View/download PDF
47. Genomic population structure associated with repeated escape of Salmonella enterica ATCC14028s from the laboratory into nature
- Author
-
Kerry K. Cooper, Mark Achtman, Philippe Lemey, Frederik Van den Broeck, Craig T. Parker, and Zhemin Zhou
- Subjects
Bacterial Diseases ,Serotype ,Cancer Research ,Salmonella ,Research Facilities ,Salmonellosis ,Single Nucleotide Polymorphisms ,QH426-470 ,Pathology and Laboratory Medicine ,medicine.disease_cause ,Medical Conditions ,Databases, Genetic ,Medicine and Health Sciences ,ATCC14028s Study Group ,Phylogeny ,Genetics (clinical) ,Data Management ,Genetics ,Likelihood Functions ,0303 health sciences ,Strain (biology) ,Salmonella enterica ,Phylogenetic Analysis ,Genomics ,Isolation (microbiology) ,Bacterial Pathogens ,Phylogenetics ,Infectious Diseases ,Medical Microbiology ,Pathogens ,Research Laboratories ,Research Article ,Computer and Information Sciences ,Biology ,Research and Analysis Methods ,Microbiology ,Evolution, Molecular ,03 medical and health sciences ,Enterobacteriaceae ,Fish Genomics ,medicine ,Evolutionary Systematics ,Domestication ,Microbial Pathogens ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics ,Taxonomy ,030304 developmental biology ,Evolutionary Biology ,Bacteria ,030306 microbiology ,QH ,Organisms ,Biology and Life Sciences ,Bayes Theorem ,Laboratory Infection ,biology.organism_classification ,Bioterrorism ,QR ,Animal Genomics ,Laboratories ,Genome, Bacterial ,Government Laboratories - Abstract
Salmonella enterica serovar Typhimurium strain ATCC14028s is commercially available from multiple national type culture collections, and has been widely used since 1960 for quality control of growth media and experiments on fitness (“laboratory evolution”). ATCC14028s has been implicated in multiple cross-contaminations in the laboratory, and has also caused multiple laboratory infections and one known attempt at bioterrorism. According to hierarchical clustering of 3002 core gene sequences, ATCC14028s belongs to HierCC cluster HC20_373 in which most internal branch lengths are only one to three SNPs long. Many natural Typhimurium isolates from humans, domesticated animals and the environment also belong to HC20_373, and their core genomes are almost indistinguishable from those of laboratory strains. These natural isolates have infected humans in Ireland and Taiwan for decades, and are common in the British Isles as well as the Americas. The isolation history of some of the natural isolates confirms the conclusion that they do not represent recent contamination by the laboratory strain, and 10% carry plasmids or bacteriophages which have been acquired in nature by HGT from unrelated bacteria. We propose that ATCC14028s has repeatedly escaped from the laboratory environment into nature via laboratory accidents or infections, but the escaped micro-lineages have only a limited life span. As a result, there is a genetic gap separating HC20_373 from its closest natural relatives due to a divergence between them in the late 19th century followed by repeated extinction events of escaped HC20_373., Author summary Clades of closely related bacteria exist in nature. Individual isolates from such clades are often distinguishable by genomic sequencing because genomic sequence differences can be acquired over a few years due to neutral drift and natural selection. The evolution of laboratory strains is often largely frozen, physically due to storage conditions and genetically due to long periods of storage. Thus, laboratory strains can normally be readily distinguished from natural isolates because they show much less diversity. However, laboratory strain ATCC14028s shows modest levels of sequence diversity because it has been shipped around the world to multiple laboratories and is routinely used for analyses of laboratory evolution. Closely related natural isolates also exist, but their genetic diversity is not dramatically greater at the core genome level. Indeed, many scientists doubt that such isolates are natural, and interpret them as undetected contamination by the laboratory strain. We present data indicating that ATCC14028s has repeatedly escaped from the laboratory through inadvertent contamination of the environment, infection of technical staff and deliberate bioterrorism. The escapees survive in nature long enough that some acquire mobile genomic elements by horizontal gene transfer, but eventually they go extinct. As a result, even extensive global databases of natural isolates lack closely related isolates whose ancestors diverged from ATCC14028s within the last 100 years.
- Published
- 2021
48. Microbiological examination of the implant abutments to evaluate the transfer of organisms from and to the laboratory.
- Author
-
Gada, Sneha, Thiyaneswaran, N., Dhanraj, M., and Jain, Ashish R.
- Subjects
- *
DENTAL abutments , *DENTAL implants , *ORAL microbiology , *DENTAL laboratories , *TRANSMISSION of pathogenic microorganisms - Abstract
Background: With the rise in the awareness about the mode of transmission of pathogens, the lights shifted onto the various procedures involving laboratory processing. The organisms transmitted from the impression to the cast and to the dental laboratory have been studied numerous times; however, the organisms transmitted back from the dental laboratory to the dental office to the patient's mouth have not been reported or recorded. Aim: The aim of the study is to evaluate the organisms transmitted from the laboratory to the dental office and vice versa transmitted from the dental office to the laboratory. Materials and Methods: Laboratories in and around the city of Chennai were chosen to collect the samples. The closed tray master impressions of the implant Stage II cases were collected. 20 samples were collected before the impressions were sent to the laboratory as well as once the dental prosthesis was received back from the laboratory. The samples were collected and cultured to study the organisms and identify the pathogenic organisms. Results: The samples sent from the dental clinic showed mainly Gram-positive cocci in clusters and pairs. However, when the same samples were received from the laboratory, some samples showed Gram-negative cocci and bacilli. However, none of the organisms found were pathogenic strains. Conclusion: Sterilization protocols should be performed, to eliminate any form of risk of infection, for the prosthesis received back from the laboratory and then inserted into the patient's mouth; similarly, the objects sent to the dental laboratory should be sterilized before they come in contact with the technician to avoid any cross-contamination. [ABSTRACT FROM AUTHOR]
- Published
- 2018
49. Cellular pathology in the COVID-19 era: a European perspective on maintaining quality and safety
- Author
-
Fernando Lopez-Rios, Giancarlo Troncone, John R. Gosney, Paul Hofman, Gosney, J. R., Hofman, P., Troncone, G., and Lopez-Rios, F.
- Subjects
safety ,0301 basic medicine ,medicine.medical_specialty ,Cellular pathology ,Coronavirus disease 2019 (COVID-19) ,media_common.quotation_subject ,Short Report ,Acute respiratory distress ,Viral infection ,Laboratory testing ,Specimen Handling ,Pathology and Forensic Medicine ,03 medical and health sciences ,0302 clinical medicine ,Pandemic ,medicine ,Global health ,Humans ,Quality (business) ,Intensive care medicine ,Occupational Health ,media_common ,Pathology, Clinical ,SARS-CoV-2 ,business.industry ,COVID-19 ,laboratory personnel ,General Medicine ,decontamination ,Laboratory Infection ,Europe ,030104 developmental biology ,030220 oncology & carcinogenesis ,Laboratories ,business ,Laboratorie ,Human - Abstract
COVID-19 is a zoonotic viral infection that originated in Wuhan, China, in late 2019. WHO classified the resulting pandemic as a ‘global health emergency’ due to its virulence and propensity to cause acute respiratory distress syndrome. The COVID-19 pandemic has had a major impact on diagnostic laboratories, particularly those handling cell and tissue specimens. This development carries serious implications for laboratory practice in that safety of personnel has to be balanced against high-quality analysis and timely reporting of results. The aim of this article is to present some recommendations for the handling of such specimens in the preanalytical, analytical and postanalytical phases of laboratory testing and analysis in an era of high COVID-19 prevalence, such as that seen, for example, in the UK, Spain, Italy and France.
- Published
- 2020
- Full Text
- View/download PDF
50. Molecular investigation of infection sources and transmission chains of brucellosis in Zhejiang, China
- Author
-
Zhiguo Liu, Hong-fang Zhang, Hua Ding, Fang Dong, Hang-yi Jin, Sujuan Zhu, Liangliang Huo, Heng Wang, Feng-yao Shao, Kuang-ji Zhu, Weimin Xu, Yi Tang, Neng-ming Jiang, Yang Yang, Zhenjun Li, Jia Wang, and Zhen-yang Tao
- Subjects
DNA, Bacterial ,0301 basic medicine ,China ,Veterinary medicine ,Zhejiang province ,Genotype ,Epidemiology ,B. abortus ,030106 microbiology ,Immunology ,Brucella abortus ,Minisatellite Repeats ,Multiple Loci VNTR Analysis ,Biology ,Microbiology ,Article ,Brucellosis ,Disease Outbreaks ,law.invention ,03 medical and health sciences ,Seroepidemiologic Studies ,law ,Virology ,Drug Discovery ,Brucella melitensis ,medicine ,Animals ,Humans ,Seroprevalence ,Phylogeny ,trace-back ,Sheep ,laboratory infection ,MLVA ,Genetic Variation ,General Medicine ,Laboratory Infection ,medicine.disease ,Brucella ,B. melitensis ,Bacterial Typing Techniques ,030104 developmental biology ,Infectious Diseases ,Transmission (mechanics) ,Infection sources ,Parasitology ,Multilocus Sequence Typing - Abstract
In the present study, a total of 7793 samples from 5 different types of hosts were collected and tested, with a seroprevalence of 2.4% (184/7793). Although the seroprevalence of human and animal brucellosis is relatively low, numbers of human brucellosis cases reported have increased continuously from 2004 to 2018. A total of 118 Brucella strains containing 4 biotypes were obtained, including Brucella melitensis bv.1 (n = 8) and bv.3 (n = 106), Brucella abortus bv.3 (n = 3) and bv.7 (n = 1). Twenty-one shared MLVA-16 genotypes, each composed of 2 to 19 strains obtained from different hosts, suggest the occurrence of a brucellosis outbreak epidemic with multiple source points and laboratory infection events. Moreover, 30 shared MLVA-16 genotypes were observed among 59.6% (68/114) B. melitensis isolates from Zhejiang and strains from other 21 different provinces, especially northern provinces, China. The analysis highlighted the imported nature of the strains from all over the northern provinces with a dominant part from the developed areas of animal husbandry. These data revealed a potential transmission pattern of brucellosis in this region, due to introduced infected sheep leading to a brucellosis outbreak epidemic, and eventually causing multiple laboratory infection events. It is urgent to strengthen the inspection and quarantine of the introduced animals.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.